Invention Grant
- Patent Title: Bispecific antibody binding to human CD26 and human CD3, production method therefor and use thereof
-
Application No.: US15554476Application Date: 2015-10-30
-
Publication No.: US10752686B2Publication Date: 2020-08-25
- Inventor: Yong Ma , Peipei Cao , Anliang Wang
- Applicant: ZONHON BIOPHARMA INSTITUTE INC. , GENSUN INSTITUTE OF BIOMEDICINE CO., LTD.
- Applicant Address: CN Changzhou CN Changzhou
- Assignee: ZONHON BIOPHARMA INSTITUTE INC.,GENSUN INSTITUTE OF BIOMEDICINE CO., LTD.
- Current Assignee: ZONHON BIOPHARMA INSTITUTE INC.,GENSUN INSTITUTE OF BIOMEDICINE CO., LTD.
- Current Assignee Address: CN Changzhou CN Changzhou
- Agency: Buchanan Ingersoll & Rooney PC
- International Application: PCT/CN2015/093383 WO 20151030
- International Announcement: WO2017/070943 WO 20170504
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/30 ; C07K16/28 ; C07K16/46 ; A61P35/00
Abstract:
Described is a bispecific antibody, and a method for producing the bispecific antibody. The bispecific antibody can be used in the preparation of a drug for treating a tumor with high cell expression of CD26. The antibody specifically hinds to human CD26 and human CD3 at the same time.
Public/Granted literature
- US20180155425A1 BISPECIFIC ANTIBODY, PRODUCTION METHOD THEREFOR AND USE THEREOF Public/Granted day:2018-06-07
Information query
